aod9604 clinical trials obesity AOD-9604 Safety Profile: What Show Obesity Pharmacotherapy: Current Perspectives and
Description
Dosage, Concentration, Route of Administration Dosage: Seek advice from a licensed physician, medical director, or other healthcare provider Concentration: 5mg/ml Route of Administration: IV/IM/SQ Resources: Precautions/Side Effects Some medications, supplements, or over-the-counter drugs may interact with methylcobalamin
Sensitivity analysis The results were insensitive to variations in the identification of cohort 2 (Table 5)
Weight loss varies depending on the individuals diet, lifestyle, and compliance
Ratziu, V
